Although adiponectin is generally referred to an anti-inflammatory and neuroprotective molecule, several clinical studies have described the so-called “adiponectin paradox”, whereby higher circulating adiponectin levels are paradoxically associated with cognitive decline, Alzheimer’s disease and frailty in older adults. Here, ADIPOQ is linked to Alzheimer disease.